ENDRA Life Sciences Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ENDRA Life Sciences Inc. on July 18, 2018. The Company is incorporated in Delaware and identifies as an emerging growth company. The report serves to disclose the posting of presentation materials to the Company's investor relations website.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure notice regarding the availability of an investor presentation rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported within the text of this filing. The primary event is the dissemination of the "July 2018 Investor Presentation" (Exhibit 99.1).
Guidance, Outlook, and Risks
The filing states that the information contained in the report and the attached Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, it is not subject to the liabilities of that section nor incorporated by reference in other filings, except as expressly set forth by specific reference. The filing does not contain specific management commentary, guidance, or risk factors within its body text.
Key Facts for Investor Verification
- Verify the contents of the "July 2018 Investor Presentation" (Exhibit 99.1) for actual financial data and strategic updates.
- Confirm the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Note that the information in this 8-K is furnished, not filed, limiting its legal liability under Section 18 of the Exchange Act.